DoW Vision, Clinical Trial Award
About
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas. Distinctive Features: · For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline. In addition, applicants must provide documentation of communication from the Regulatory Agency indicating that the IND/IDE or equivalent is active/safe to proceed by March 1, 2027, in order for the CTA application to be considered for funding. Refer to Attachment 7: Regulatory Strategy for further details. · Scored peer review criteria include Clinical Impact; Research Strategy and Feasibility; Recruitment, Accrual, Retention; Regulatory Strategy and Transition Plan; Statistical Plan and Data Analysis; Ethical Considerations; Personnel and Communication. · Programmatic review criteria include adherence to the intent of the CTA, contribution to program portfolio, relative impact and relevance to military health. https://cdmrp. health. mil/pubs/press/2026/vrppreann.
The DoW Vision, Clinical Trial Award is a federal grant program designed to support researchers and clinical teams implementing innovative clinical trials focused on treating or managing service-connected eye injuries and visual dysfunction. This program is ideal for academic medical centers, research institutions, and healthcare organizations with the capacity to conduct rigorous clinical trials that address military health needs. The award prioritizes interventions with significant potential impact on vision care outcomes for service members and veterans. Applicants must align their research with FY26 Vision Research Program Focus Areas and demonstrate feasibility in recruitment, retention, and regulatory compliance. The program is particularly suited for teams with established regulatory pathways (IND/IDE approvals) and strong clinical expertise. If your organization conducts vision research with military relevance and has the infrastructure to manage complex clinical trials, this grant offers an opportunity to advance evidence-based treatments while contributing to the Department of Defense's research portfolio. Successful applicants will have demonstrated clinical impact potential, comprehensive research strategies, and personnel qualified to execute high-quality trials.
Funding Facts
● Applications openDeadline
November 12, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Not specified - contact program for details
Deadline
2026-11-12
Grant Type
federal
Application Cycle
Annual (FY26 deadline: November 12, 2026)
Best For
Academic medical centers, research institutions, and healthcare organizations conducting vision research with military health relevance
Frequently Asked Questions
Who is eligible for DoW Vision, Clinical Trial Award?
Specific eligibility criteria are not detailed in the available information. The program is administered by the Department of Defense's Congressionally Directed Medical Research Programs (CDMRP) and typically supports academic institutions, research centers, and healthcare organizations capable of conducting clinical trials. For complete eligibility requirements, visit the official program announcement at https://cdmrp.health.mil/pubs/press/2026/vrppreann
How much funding does DoW Vision, Clinical Trial Award provide?
The specific funding amount is not specified in the available program details. Funding varies by fiscal year and project scope. Contact the program directly or review the official program announcement at https://cdmrp.health.mil/pubs/press/2026/vrppreann for current funding information.
How do I apply for DoW Vision, Clinical Trial Award?
Applications are submitted through the CDMRP portal. The FY26 application deadline is November 12, 2026. Critical to note: for interventions requiring IND/IDE or equivalent regulatory authorizations, the IND/IDE application must be submitted to the relevant Regulatory Agency by the application deadline, with documentation of active status required by March 1, 2027. Visit https://cdmrp.health.mil/pubs/press/2026/vrppreann for detailed application instructions and access to the submission portal.
What can DoW Vision, Clinical Trial Award funding be used for?
This award supports the rapid implementation of clinical trials addressing service-connected eye injury and visual dysfunction. Research must align with at least one FY26 Vision Research Program Focus Area. Funding supports trials with interventions that have significant potential impact on treatment or management of vision-related conditions. Peer review emphasizes clinical impact, research feasibility, recruitment and retention strategies, regulatory compliance, statistical rigor, ethical considerations, and personnel qualifications.
Last updated: July 5, 2026